Mark G. Bock
Impact in
- Organic Chemistry top 1%
- Synthesis and biological activity
- Multicomponent Synthesis of Heterocycles
- Asymmetric Synthesis and Catalysis
-
- Neuropeptides and Animal Physiology
Papers in
-
- Receptor Mechanisms and Signaling 20
- Chemical Synthesis and Analysis 20
-
- Neuropeptides and Animal Physiology 31
- Co-authors
- Robert M. DiPardo (50 shared papers)Roger Freidinger (56 shared papers)B. Evans (28 shared papers)Kenneth E. Rittle (22 shared papers)Daniel F. Veber (26 shared papers)Willie L. Whitter (14 shared papers)Paul Anderson (10 shared papers)E. J. Corey (6 shared papers)
- Journals
- Journal of Medicinal Chemistry (25 papers)Bioorganic & Medicinal Chemistry Letters (18 papers)Tetrahedron Letters (10 papers)Journal of Pharmacology and Experimental Therapeutics (5 papers)European Journal of Pharmacology (4 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Mark G. Bock
114 papers receiving 3.9k citations
Mark G. Bock's Hit Papers
Peers
Comparison fields: 5 of 113
- Organic Chemistry 1.9k
- Cellular and Molecular Neuroscience 964
- Toxicology 136
- Molecular Biology 2.1k
- Genetics 297
Countries citing papers authored by Mark G. Bock
This map shows the geographic impact of Mark G. Bock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark G. Bock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark G. Bock more than expected).
Fields of papers citing papers by Mark G. Bock
This network shows the impact of papers produced by Mark G. Bock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark G. Bock. The network helps show where Mark G. Bock may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark G. Bock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 116 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists Hit paper breakdown → | 1988 | 1269 |
| 2 | 1986 | 289 | |
| 3 | 1989 | 278 | |
| 4 | 1976 | 116 | |
| 5 | 1989 | 85 | |
| 6 | 1994 | 82 | |
| 7 | 2003 | 71 | |
| 8 | 1975 | 69 | |
| 9 | 2005 | 67 | |
| 10 | 1992 | 60 | |
| 11 | 1987 | 60 | |
| 12 | 1987 | 59 | |
| 13 | 1975 | 57 | |
| 14 | 1997 | 57 | |
| 15 | 1998 | 56 | |
| 16 | 1993 | 54 | |
| 17 | 2009 | 52 | |
| 18 | 2000 | 46 | |
| 19 | 1978 | 45 | |
| 20 | 2004 | 42 |
About Mark G. Bock
Mark G. Bock is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Organic Chemistry, Genetics and Social Psychology, having authored 116 papers that have together received 4.2k indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (31 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (24 papers), Receptor Mechanisms and Signaling (20 papers), Chemical Synthesis and Analysis (20 papers), Neuroendocrine regulation and behavior (17 papers), Peptidase Inhibition and Analysis (12 papers), Organic and Inorganic Chemical Reactions (7 papers) and Bioactive Compounds and Antitumor Agents (6 papers). The work is most often cited by research in Organic Chemistry (1.9k citations), Cellular and Molecular Neuroscience (964 citations), Toxicology (136 citations), Molecular Biology (2.1k citations) and Genetics (297 citations). Mark G. Bock has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Robert M. DiPardo, Roger Freidinger, B. Evans, Kenneth E. Rittle, Daniel F. Veber, Willie L. Whitter, Paul Anderson, E. J. Corey, Raymond S.L. Chang and Victor J. Lotti. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.